A new study reveals how targeted electromagnetic waves can disrupt the SARS-CoV-2 spike protein, potentially opening doors to innovative disinfection and infection control strategies. Study: ...
Neutralizing antibodies that merely block receptor binding are losing ground against heavily mutated SARS-CoV-2 Omicron sub-variants. A new approach now exploits a llama-derived nanobody—VHH21—that ...
Monoclonal antibodies (mAbs) are vital for preventing and treating COVID-19 by targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein. However, the rapid emergence of Omicron ...
The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...
The US Food and Drug Administration has greenlit a next-generation COVID-19 vaccine from Moderna that’s engineered to be given in a smaller dose than the current one and targets certain portions of ...
A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into a hypothesis about the origin of Alzheimer's disease. In a new study ...
Imagine you're a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know you need the expertise of a virologist and an immunologist, plus a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback